The New Report Collection Platform

Eliminates Information Barriers and Empowers Your Business Decisions!

 

If there are more needs or suggestions

Please contact us

E-mail:sales@bossonresearch.com

Global Induced Pluripotent Stem Cells (iPSc) Market Market Research Report 2021(Status and Outlook)

img1

Report Overview:

Induced pluripotent stem cells are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery.

Bosson Research’s latest report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from macro overview of the market to micro details of the market size, competitive landscape ,development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps to shape the competition within the industries and strategies to the competitive environment in order to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of Global Induced Pluripotent Stem Cells (iPSc) Market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.

Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Market segmentation creates subsets of a market based on product type, end user or application, Geographic, and other factor. By understanding the market segments, decision maker can leverage this targeting in product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

By Company

Type Segmentation

l                      Lonza

l                      Axol Bioscience Ltd.

l                      Evotec

l                      Hitachi Ltd.

l                      Merck KGaA

l                      REPROCELL Inc.

l                      Fate Therapeutics

l                      Thermo Fisher Scientific, Inc.

l                      StemCellFactory III

l                      Applied StemCell Inc.

l                      Fujifilm Holding Corporation (CDI)

l                      Ncardia

l                      Sumitomo Dainippon harma

l                      Astellas Pharma Inc

l                      Pluricell Biotech

l                      Cell Inspire Biotechnology

l                      Hepatocytes

l                      Fibroblasts

l                      Keratinocytes

l                      Amniotic Cells

Application Segmentation

l                      Academic Research

l                      Drug Development and Discovery

l                      Toxicity Screening

l                      Regenerative Medicine

l                      Others



Overview of the Regional Outlook of the Induced Pluripotent Stem Cells (iPSc) Market:

Geographic Segmentation (M USD)

2017

2021

2028

Share (2021)

CAGR (2021-2028)

North America

USA

XX

XX

XX

XX%

XX%

Canada

XX

XX

XX

XX%

XX%

Mexico

XX

XX

XX

XX%

XX%

Europe

Germany

XX

XX

XX

XX%

XX%

UK

XX

XX

XX

XX%

XX%

France

XX

XX

XX

XX%

XX%

Russia

XX

XX

XX

XX%

XX%

Italy

XX

XX

XX

XX%

XX%

Rest of Europe

XX

XX

XX

XX%

XX%

Asia-Pacific

China

XX

XX

XX

XX%

XX%

Japan

XX

XX

XX

XX%

XX%

South Korea

XX

XX

XX

XX%

XX%

India

XX

XX

XX

XX%

XX%

Southeast Asia

XX

XX

XX

XX%

XX%

Rest of Asia-Pacific

XX

XX

XX

XX%

XX%

South America

Brazil

XX

XX

XX

XX%

XX%

Argentina

XX

XX

XX

XX%

XX%

Columbia

XX

XX

XX

XX%

XX%

Rest of South America

XX

XX

XX

XX%

XX%

Middle East and Africa

Saudi Arabia

XX

XX

XX

XX%

XX%

UAE

XX

XX

XX

XX%

XX%

Egypt

XX

XX

XX

XX%

XX%

Nigeria

XX

XX

XX

XX%

XX%

South Africa

XX

XX

XX

XX%

XX%

Rest of MEA

XX

XX

XX

XX%

XX%

Global

XX

XX

XX

XX

XX%


Key Benefits of This Market Research:

 Industry drivers, restraints, and opportunities covered in the study

 Neutral perspective on the market performance

 Recent industry trends and developments

 Competitive landscape & strategies of key players

 Potential & niche segments and regions exhibiting promising growth covered

 Historical, current, and projected market size, in terms of value

 In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market

 Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:


Key Reasons to Buy this Report:

 Access to up to date statistics compiled by our own researchers. These provide you with historical and forecast data, which is analysed to tell you why your market is set to change

 This enables you to anticipate market changes in order to remain ahead of your competitors

 You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentation or other strategic documents

 The concise analysis, clear graph and table format will enable you to pin point the information your require quickly

 Provision of market value (USD Billion) data for each segment and sub-segment

 Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

 Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

 Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

 Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

 The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

 Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis

 Provides insight into the market through Value Chain

 Market dynamics scenario, along with growth opportunities of the market in the years to come

 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are meet.


Table of Contents

1 Induced Pluripotent Stem Cells (iPSc) Market Competitive Landscape        

1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2017-2022)        

1.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2017-2022)        

1.3 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)        

1.4 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2017-2022)        

1.5 Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites, Area Served, Product Type        

1.6 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends        

1.6.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate        

1.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue        

1.6.3 Mergers & Acquisitions, Expansion        

2 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis        

2.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis        

2.2 Market Overview and Market Concentration Analysis of Key Raw Materials        

2.3 Midstream Market Analysis        

2.4 Downstream Customer Analysis        

3 The Development and Dynamics of Induced Pluripotent Stem Cells (iPSc) Market        

3.1 Key Development Trends        

3.2 Driving Factors        

3.3 Market Challenges        

3.4 Market Restraints        

3.5 Industry News        

3.5.1 New Product Developments        

3.5.2 Mergers & Acquisitions        

3.5.3 Expansions        

3.5.4 Collaboration/Supply Contracts        

3.6 Industry Policies        

4 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Type        

4.1 Evaluation Matrix of Segment Market Development Potential (Type)        

4.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)        

4.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2017-2022)        

4.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2017-2022)        

5 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Application        

5.1 Evaluation Matrix of Segment Market Development Potential (Application)        

5.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2017-2022)        

5.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2017-2022)        

5.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)        

6 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Region        

6.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region        

6.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region        

6.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region        

6.2 North America        

6.2.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country        

6.2.2 U.S.        

6.2.3 Canada        

6.2.4 Mexico        

6.3 Europe        

6.3.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country        

6.3.2 Germany        

6.3.3 France        

6.3.4 U.K.        

6.3.5 Italy        

6.3.6 Russia        

6.4 Asia Pacific        

6.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region        

6.4.2 China        

6.4.3 Japan        

6.4.4 South Korea        

6.4.5 India        

6.4.6 Southeast Asia        

6.5 South America        

6.5.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country        

6.5.2 Brazil        

6.5.3 Argentina        

6.5.4 Columbia        

6.6 Middle East and Africa        

6.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region        

6.6.2 Saudi Arabia        

6.6.3 UAE        

6.6.4 Egypt        

6.6.5 Nigeria        

6.6.6 South Africa        

7 Key Companies Profiled        

7.1 Lonza        

7.1.1 Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.1.4 Lonza Business Overview        

7.1.5 Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

7.1.6 Lonza Recent Developments        

7.2 Axol Bioscience Ltd.        

7.2.1 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.2.4 Axol Bioscience Ltd. Business Overview        

7.2.5 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

7.2.6 Axol Bioscience Ltd. Recent Developments        

7.3 Evotec        

7.3.1 Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.3.4 Evotec Business Overview        

7.3.5 Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

7.3.6 Evotec Recent Developments        

7.4 Hitachi Ltd.        

7.4.1 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.4.4 Hitachi Ltd. Business Overview        

7.4.5 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

7.4.6 Hitachi Ltd. Recent Developments        

7.5 Merck KGaA        

7.5.1 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.5.4 Merck KGaA Business Overview        

7.5.5 Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

7.5.6 Merck KGaA Recent Developments        

7.6 REPROCELL Inc.        

7.6.1 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.6.4 REPROCELL Inc. Business Overview        

7.6.5 REPROCELL Inc. Recent Developments        

7.7 Fate Therapeutics        

7.7.1 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.7.4 Fate Therapeutics Business Overview        

7.7.5 Fate Therapeutics Recent Developments        

7.8 Thermo Fisher Scientific, Inc.        

7.8.1 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.8.4 Thermo Fisher Scientific, Inc. Business Overview        

7.8.5 Thermo Fisher Scientific, Inc. Recent Developments        

7.9 StemCellFactory III        

7.9.1 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.9.4 StemCellFactory III Business Overview        

7.9.5 StemCellFactory III Recent Developments        

7.10 Applied StemCell Inc.        

7.10.1 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.10.4 Applied StemCell Inc. Business Overview        

7.10.5 Applied StemCell Inc. Recent Developments        

7.11 Fujifilm Holding Corporation (CDI)        

7.11.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.11.4 Fujifilm Holding Corporation (CDI) Business Overview        

7.11.5 Fujifilm Holding Corporation (CDI) Recent Developments        

7.12 Ncardia        

7.12.1 Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.12.4 Ncardia Business Overview        

7.12.5 Ncardia Recent Developments        

7.13 Sumitomo Dainippon harma        

7.13.1 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.13.4 Sumitomo Dainippon harma Business Overview        

7.13.5 Sumitomo Dainippon harma Recent Developments        

7.14 Astellas Pharma Inc        

7.14.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.14.4 Astellas Pharma Inc Business Overview        

7.14.5 Astellas Pharma Inc Recent Developments        

7.15 Pluricell Biotech        

7.15.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.15.4 Pluricell Biotech Business Overview        

7.15.5 Pluricell Biotech Recent Developments        

7.16 Cell Inspire Biotechnology        

7.16.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information        

7.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview        

7.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance        

7.16.4 Cell Inspire Biotechnology Business Overview        

7.16.5 Cell Inspire Biotechnology Recent Developments        

8 Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region        

8.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast        

8.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region        

8.2.1 North America Market Size Forecast by Country        

8.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country        

8.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region        

8.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country        

8.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSc) by Country        

List of Tables

Table 1. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Manufacturers (2017-2022)        

Table 2. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Manufacturers (2017-2022)        

Table 3. Global Induced Pluripotent Stem Cells (iPSc) Revenue (M USD) by Manufacturers (2017-2022)        

Table 4. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers (2017-2022)        

Table 5. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSc) as of 2020)        

Table 6. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/Unit) of Key Manufacturers (2017-2022)        

Table 7. Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites and Area Served        

Table 8. Manufacturers Induced Pluripotent Stem Cells (iPSc) Product Type        

Table 9. Global Induced Pluripotent Stem Cells (iPSc) Manufacturers Market Concentration Ratio (CR5 and HHI)        

Table 10. Mergers & Acquisitions, Expansion Plans        

Table 11. Industry Chain Map of Induced Pluripotent Stem Cells (iPSc)        

Table 12. Raw Materials        

Table 13. Midstream Market Analysis        

Table 14. Downstream Customer Analysis        

Table 15. Key Development Trends        

Table 16. Driving Factors        

Table 17. Induced Pluripotent Stem Cells (iPSc) Market Challenges        

Table 18. Market Restraints        

Table 19. Global Induced Pluripotent Stem Cells (iPSc) Sales by Type (K Units)        

Table 20. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Type (M USD)        

Table 21. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Type (2017-2022)        

Table 22. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)        

Table 23. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Type (2017-2022)        

Table 24. Global Induced Pluripotent Stem Cells (iPSc) Market Size Share by Type (2017-2022)        

Table 25. Global Induced Pluripotent Stem Cells (iPSc) Price (USD/Unit) by Type (2017-2022)        

Table 26. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) by Application        

Table 27. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application        

Table 28. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (K Units)        

Table 29. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2017-2022)        

Table 30. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2017-2022) & (M USD)        

Table 31. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022)        

Table 32. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)        

Table 33. Global Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units)        

Table 34. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022)        

Table 35. North America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units)        

Table 36. Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units)        

Table 37. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units)        

Table 38. South America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2017-2022) & (K Units)        

Table 39. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region (2017-2022) & (K Units)        

Table 40. Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 41. Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 42. Lonza Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 43. Lonza Business Overview        

Table 44. Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

Table 45. Lonza Recent Developments        

Table 46. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 47. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 48. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 49. Axol Bioscience Ltd. Business Overview        

Table 50. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

Table 51. Axol Bioscience Ltd. Recent Developments        

Table 52. Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 53. Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 54. Evotec Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 55. Evotec Business Overview        

Table 56. Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

Table 57. Evotec Recent Developments        

Table 58. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 59. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 60. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 61. Hitachi Ltd. Business Overview        

Table 62. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

Table 63. Hitachi Ltd. Recent Developments        

Table 64. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 65. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 66. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 67. Merck KGaA Business Overview        

Table 68. Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis        

Table 69. Merck KGaA Recent Developments        

Table 70. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 71. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 72. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 73. REPROCELL Inc. Business Overview        

Table 74. REPROCELL Inc. Recent Developments        

Table 75. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 76. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 77. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 78. Fate Therapeutics Business Overview        

Table 79. Fate Therapeutics Recent Developments        

Table 80. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 81. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 82. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 83. Thermo Fisher Scientific, Inc. Business Overview        

Table 84. Thermo Fisher Scientific, Inc. Recent Developments        

Table 85. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 86. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 87. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 88. StemCellFactory III Business Overview        

Table 89. StemCellFactory III Recent Developments        

Table 90. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 91. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 92. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 93. Applied StemCell Inc. Business Overview        

Table 94. Applied StemCell Inc. Recent Developments        

Table 95. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 96. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 97. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 98. Fujifilm Holding Corporation (CDI) Business Overview        

Table 99. Fujifilm Holding Corporation (CDI) Recent Developments        

Table 100. Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 101. Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 102. Ncardia Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 103. Ncardia Business Overview        

Table 104. Ncardia Recent Developments        

Table 105. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 106. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 107. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 108. Sumitomo Dainippon harma Business Overview        

Table 109. Sumitomo Dainippon harma Recent Developments        

Table 110. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 111. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 112. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 113. Astellas Pharma Inc Business Overview        

Table 114. Astellas Pharma Inc Recent Developments        

Table 115. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 116. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 117. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 118. Pluricell Biotech Business Overview        

Table 119. Pluricell Biotech Recent Developments        

Table 120. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information        

Table 121. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview        

Table 122. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)        

Table 123. Cell Inspire Biotechnology Business Overview        

Table 124. Cell Inspire Biotechnology Recent Developments        

Table 125. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (K Units)        

Table 126. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (M USD)        

Table 127. North America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units)        

Table 128. North America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD)        

Table 129. Europe Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units)        

Table 130. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD)        

Table 131. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2022-2028) & (K Units)        

Table 132. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2022-2028) & (M USD)        

Table 133. South America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2022-2028) & (K Units)        

Table 134. South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD)        

Table 135. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Consumption Forecast by Country (2022-2028) & (Units)        

Table 136. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2022-2028) & (M USD)        

Table 137. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Type (2022-2028) & (K Units)        

Table 138. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028) & (M USD)        

Table 139. Global Induced Pluripotent Stem Cells (iPSc) Price Forecast by Type (2022-2028) & (USD/Unit)        

Table 140. Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application (2022-2028)        

Table 141. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Application (2022-2028) & (M USD)        


List of Figures

Figure 1. Induced Pluripotent Stem Cells (iPSc) Sales Share by Manufacturers in 2020        

Figure 2. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers in 2020        

Figure 3. Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020        

Figure 4. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/Unit) of Key Manufacturers in 2020        

Figure 5. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSc) Revenue in 2020        

Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)        

Figure 7. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Type        

Figure 8. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022)        

Figure 9. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020        

Figure 10. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type (2017-2022)        

Figure 11. Market Size Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2020        

Figure 12. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application        

Figure 13. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2017-2022)        

Figure 14. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application in 2020        

Figure 15. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2017-2022)        

Figure 16. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application in 2020        

Figure 17. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)        

Figure 18. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2017-2022)        

Figure 19. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 20. North America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020        

Figure 21. U.S. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 22. Canada Induced Pluripotent Stem Cells (iPSc) Sales (K Units) and Growth Rate (2017-2022)        

Figure 23. Mexico Induced Pluripotent Stem Cells (iPSc) Sales (Units) and Growth Rate (2017-2022)        

Figure 24. Europe Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 25. Europe Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020        

Figure 26. Germany Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 27. France Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 28. U.K. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 29. Italy Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 30. Russia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 31. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units)        

Figure 32. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2020        

Figure 33. China Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 34. Japan Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 35. South Korea Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 36. India Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 37. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 38. South America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units)        

Figure 39. South America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2020        

Figure 40. Brazil Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 41. Argentina Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 42. Columbia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 43. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K Units)        

Figure 44. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2020        

Figure 45. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 46. UAE Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 47. Egypt Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 48. Nigeria Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 49. South Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2017-2022) & (K Units)        

Figure 50. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Volume (2017-2028) & (K Units)        

Figure 51. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Value (2017-2028) & (M USD)        

Figure 52. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share Forecast by Type (2022-2028)        

Figure 53. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Type (2022-2028)        

Figure 54. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Application (2022-2028)        

Figure 55. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Application (2022-2028)        




Custom Report
Created on:2022-01-22
Collect